Lab21 in America

Lab21 Inc is the US subsidiary for Lab21 Ltd, formed following the acquisition of Selah Technologies in December 2009. Our US headquarters and newly constructed laboratory are in Greenville, South Carolina.

Leveraging the best practices of our acclaimed diagnostic service laboratories in the United Kingdom, our new 7.500 ft2 CLIA laboratory (#42D2027903) is designed and equipped to provide advanced diagnostic services with a focus on enabling personalized medicine for oncology and virology including sequencing and HPLC/mass spec.  We will offer both routine diagnostic services and clinical trial support.

Our initial virology portfolio will include:

• HIV Tropism Genotype
• HIV Tropism Phenotype
• HIV Viral Load
• HIV Drug Resistance
• HCV Viral Load
• HCV Genotyping

Lab21 will also offer CancerPath™, a diagnostic service that informs therapeutic guidance for oncology.

Location

Greenville is found in the Upstate, or NW, region of South Carolina. Just off I-85, halfway between Atlanta, Georgia and Charlotte, North Carolina. 

Home to Lab21 US Headquarters and CLIA Lab, NEXT Center, Greenville SC

The new Lab21 US laboratory is located in the NEXT Center on the banks of Reedy River in downtown Greenville, South Carolina.   
 

Blocks from Lab21, Liberty Bridge, Falls Park, Greenville SC

Lab21’s new home is designed to empower our innovative and engaged workforce: our employees can exercise along the park paths, ride bikes to work or walk to Main Street for lunch.